The antitumor activity of Meconopsis horridula Hook, a traditional Tibetan medical plant, in murine leukemia L1210 cells. 2015

Jianping Fan, and Yaqin Wang, and Xiaobing Wang, and Pan Wang, and Wei Tang, and Wenjuan Yuan, and Lulu Kong, and Quanhong Liu

BACKGROUND Meconopsis horridula Hook (M. horridula) has been used as a traditional Tibetan medicine to relieve heat and pain as well as mobilize static blood, and it is recognized as a good treatment for bruises. This study is the first trial to evaluate the tumor inhibitory activity of M. horridula extract and its underlying mechanism in the hope of providing evidence to support the anticancer function of M. horridula. RESULTS M. horridula extract was cytotoxic to L1210 cells in a dose- and time-dependent manner. SEM (scanning electron microscope) observation revealed obvious morphological changes in L1210 cells after M. horridula treatment. Flow cytometry analysis demonstrated that the extract dose-dependently induced early apoptosis. Additional apoptosis parameters, such as alterations in nuclear morphology and DNA damage, were also observed. Furthermore, M. horridula treatment induced G2/M arrest. M. horridula treatment significantly increased reactive oxygen species (ROS) production, suggesting that ROS are a key factor in M. horridula-induced apoptosis. Volatile constituent detection found 15 abundant chemicals in M. horridula, which may contribute to its anticancer effect. CONCLUSIONS In conclusion, M. horridula extract induced L1210 cell apoptosis and inhibited proliferation through G2/M phase arrest, and ROS were involved in the process.

UI MeSH Term Description Entries
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004365 Drugs, Chinese Herbal Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesized compounds manufactured in China. Chinese Herbal Drugs,Plant Extracts, Chinese,Chinese Drugs, Plant,Chinese Plant Extracts,Extracts, Chinese Plant,Herbal Drugs, Chinese
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000972 Antineoplastic Agents, Phytogenic Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. Antineoplastics, Botanical,Antineoplastics, Phytogenic,Agents, Phytogenic Antineoplastic,Botanical Antineoplastics,Phytogenic Antineoplastic Agents,Phytogenic Antineoplastics
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D017382 Reactive Oxygen Species Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS. Active Oxygen Species,Oxygen Radical,Oxygen Radicals,Pro-Oxidant,Reactive Oxygen Intermediates,Active Oxygen,Oxygen Species, Reactive,Pro-Oxidants,Oxygen, Active,Pro Oxidant,Pro Oxidants,Radical, Oxygen
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Jianping Fan, and Yaqin Wang, and Xiaobing Wang, and Pan Wang, and Wei Tang, and Wenjuan Yuan, and Lulu Kong, and Quanhong Liu
April 2014, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
Jianping Fan, and Yaqin Wang, and Xiaobing Wang, and Pan Wang, and Wei Tang, and Wenjuan Yuan, and Lulu Kong, and Quanhong Liu
October 2017, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
Jianping Fan, and Yaqin Wang, and Xiaobing Wang, and Pan Wang, and Wei Tang, and Wenjuan Yuan, and Lulu Kong, and Quanhong Liu
March 1980, Cancer research,
Jianping Fan, and Yaqin Wang, and Xiaobing Wang, and Pan Wang, and Wei Tang, and Wenjuan Yuan, and Lulu Kong, and Quanhong Liu
March 2021, Mitochondrial DNA. Part B, Resources,
Jianping Fan, and Yaqin Wang, and Xiaobing Wang, and Pan Wang, and Wei Tang, and Wenjuan Yuan, and Lulu Kong, and Quanhong Liu
January 1981, Cancer chemotherapy and pharmacology,
Jianping Fan, and Yaqin Wang, and Xiaobing Wang, and Pan Wang, and Wei Tang, and Wenjuan Yuan, and Lulu Kong, and Quanhong Liu
July 2019, Mitochondrial DNA. Part B, Resources,
Jianping Fan, and Yaqin Wang, and Xiaobing Wang, and Pan Wang, and Wei Tang, and Wenjuan Yuan, and Lulu Kong, and Quanhong Liu
October 2007, The Journal of veterinary medical science,
Jianping Fan, and Yaqin Wang, and Xiaobing Wang, and Pan Wang, and Wei Tang, and Wenjuan Yuan, and Lulu Kong, and Quanhong Liu
January 1978, Biokhimiia (Moscow, Russia),
Jianping Fan, and Yaqin Wang, and Xiaobing Wang, and Pan Wang, and Wei Tang, and Wenjuan Yuan, and Lulu Kong, and Quanhong Liu
August 1999, General pharmacology,
Jianping Fan, and Yaqin Wang, and Xiaobing Wang, and Pan Wang, and Wei Tang, and Wenjuan Yuan, and Lulu Kong, and Quanhong Liu
January 1995, Anticancer research,
Copied contents to your clipboard!